Navigation Links
Abbreviated Trials Yield Misleading Results: Study
Date:3/23/2010

Researchers must resist pressure for early halt, expert says

TUESDAY, March 23 (HealthDay News) -- Many positive treatment effects are exaggerated in clinical trials that are stopped early due to encouraging results, a new study has found.

In a comparison of 91 truncated trials with 424 comparable full-length trials, researchers found that the trials that ended early -- in particular, smaller studies -- reported exaggerated or misleading treatment effects.

"Our research shows that in most cases, early stopping of clinical trials resulted in misleading estimates of treatment effects. These misleading estimates are likely to result in misguided decisions about the trade-off between risks and benefits of a therapy," study corresponding author Dr. Victor Montori, a Mayo Clinic endocrinologist, said in a news release.

"On average, treatments with no effect would show a reduction in relative risk of almost 30 percent in stopped early trials. Treatments with a true relative risk reduction of 20 percent would show a reduction of over 40 percent," Montori said.

Almost everyone -- doctors, researchers, funding sources, drug makers, medical journals -- benefits from a clinical trial ending early, Montori noted. But patients don't benefit because they may end up receiving a therapy on the basis of misleading information about its benefits.

Montori and colleagues said that researchers must resist pressure to end clinical trials early and continue trials until they're nearly completed before even considering an early halt.

The study was published March 23 in the Journal of the American Medical Association.

More information

The U.S. National Institutes of Health has more about clinical trials.



-- Robert Preidt



SOURCE: Mayo Clinic, news release, March 23, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. FDA Issues Guidance to Help Streamline Medical Device Clinical Trials
2. European Cancer Organization supports a revision of the EU Clinical Trials Directive
3. Human guinea pigs wary of high-paying medical trials
4. Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines
5. ePRO on Netbooks (NetPRO) - The BEST ePRO Solution for Clinical Trials in 15 Years
6. Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
7. Mesothelioma Clinical Trials List Offered by IQ Mesothelioma: Search Current Mesothelioma Treatment Options
8. State payer mandates to cover cancer trials offer heterogeneous protection for patients
9. LSUHSC research yields promising stroke treatment
10. Compulsive Dogs Yield Clues to Human OCD, Autism
11. Battlefield camaraderie yields long-term dividends for veterans, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, the leading ... of a free, public-facing tool for analyzing the costs of various drug regimens ... comparative information to patients, providers, insurers and pharmaceutical companies about the estimated costs ...
(Date:3/28/2017)... ... ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; Dr. Jennifer ... speak to the press on behalf of over 200 doctors, scientists, and scientific organizations ... , WHERE: , Zenger Room, National Press Club, 529 14th Street NW, 13th ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... are critical to ensuring high-quality results and maintaining GMP and USP compliance. In ... Instruments in accordance with GMP requirements " these requirements are explained. The ...
(Date:3/28/2017)... ... 2017 , ... Neurotechnology , a provider of high-precision ... tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the updated  ... recognition to enable users to check in and out from anywhere via the ...
(Date:3/28/2017)... WI (PRWEB) , ... March 28, 2017 , ... ... self-funded health plans work, the Self-Funding Success website has recently developed and published ... Self-Funded Health Plans ” was created based on common inquiries the site’s team ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 29, 2017 Center Point Clinical ... platform, announced today study results presented in two ... #AMCP2017, Managed Care and Specialty Pharmacy annual meeting ... in both posters demonstrated that pharmacist-led patient interventions during ... These factors are crucial to generating the robust and ...
(Date:3/28/2017)... This morning,s research on ... The Medicines Co. (NASDAQ: MDCO), Ironwood Pharmaceuticals Inc. ... Supernus Pharmaceuticals Inc. (NASDAQ: SUPN ). ... which is governed by the same governing framework ... industry are wholesalers, retailers, pharmacies, and benefit managers. Learn ...
(Date:3/28/2017)... ROCKVILLE, Md. , March 28, 2017 /PRNewswire/ ... dedicated to innovative therapeutics addressing cancer and other ... at the American Association for Cancer Research annual ... April 3 is entitled "Evaluation of ENMD-2076 ... and the second poster to be presented ...
Breaking Medicine Technology: